search
Back to results

NIR Arthroscopic Fluorescence Angiography of Menisci (FLUORarth)

Primary Purpose

Meniscus Rupture

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
NIR fluorescence imaging of the vascular perfusion of the meniscus using ICG
Sponsored by
Isala
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Meniscus Rupture

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 18 years or older;
  • Patients with on MRI confirmed Zone 1 meniscal tear
  • Patients with a clinical indication for arthroscopic meniscal repair
  • Before patient registration, written consent must be given according to ICH/GCP, national and local regulations.

Exclusion Criteria:

  • Prior operative treatment of the ruptured meniscus
  • Any condition that in the opinion of the investigator could potentially jeopardize the health status of the patient. In specific, these conditions concern smoking, diabetes and being overweight.
  • Pregnancy
  • allergy to iodine, shellfish or ICG;
  • Psychological, familial sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial;

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    NIR fluorescence

    Arm Description

    The included patients will be subdivided in four equal subgroups in order to evaluate alteration of NIR fluorescence signal during arthroscopy in combination with a (temporary) tourniquet and irrigation pump system.

    Outcomes

    Primary Outcome Measures

    NIR fluorescence of the meniscus
    Detection of fluorescence in the meniscus (yes/no), determined intra-operatively during the arthroscopy procedure using NIR fluorescence imaging and ICG.

    Secondary Outcome Measures

    T start
    Time between injection of ICG and initial detection of the fluorescence signal in the meniscus (T start).
    I max
    Maximum fluorescence intensity (Imax) in the meniscus. Fluorescence intensity will be measured in arbitrary units as a mean of three different region of interests.
    T max
    Time to maximum intensity of the fluorescence signal
    Baseline and End fluorescence intensity
    Baseline fluorescence intensity of the meniscus and the end fluorescence intensity in the meniscus
    The ration between the maximum fluorescence intensity in the meniscus and the background fluorecence intensity.
    The fluorescence intensity is measured in arbitrary units as a mean of three region of interests.

    Full Information

    First Posted
    June 7, 2022
    Last Updated
    June 11, 2022
    Sponsor
    Isala
    Collaborators
    Arthrex, Inc., Diagnostic Green GmbH
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05420974
    Brief Title
    NIR Arthroscopic Fluorescence Angiography of Menisci
    Acronym
    FLUORarth
    Official Title
    Intraoperative Arthroscopic Near-infrared Fluorescence Imaging of the Vascular Perfusion of the Meniscus in Patients Treated With Meniscal Repair
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    September 1, 2022 (Anticipated)
    Primary Completion Date
    August 31, 2023 (Anticipated)
    Study Completion Date
    October 31, 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Isala
    Collaborators
    Arthrex, Inc., Diagnostic Green GmbH

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    This trial is an explorative single center, single-arm study to assess whether vascularization of the meniscus can be visualized intraoperatively using arthroscopic near-infrared (NIR) fluorescence using ICG during standard of care meniscal repair treatment.
    Detailed Description
    The meniscal healing process is based on two fundamental principles: a solid primary fixation, and a well-functioning biological process of cicatrization, where the presence of vascularization is thought to play a major role. Intra-operative near infrared fluorescence angiography using Indocyanine Green (ICG) is a widely used method for operative assessment of vascularization. Fluorescence guided detection of the vascularity surrounding a meniscal tear could be of great value to predict meniscal healing after repair. This pilot study will explore the technical feasibility of intraoperative near-infrared fluorescence angiography of the meniscus in patients undergoing arthroscopic meniscal repair. Technical challenges for NIR fluorescence arthroscopy are the visibility of the vascular perfusion in microvessels in the dense meniscus, motion artifacts encountered with arthroscopy and wash in of ICG using a fluid irrigation system. The included patients will be subdivided in four equal subgroups in order to evaluate alteration of NIR fluorescence signal during arthroscopy in combination with a tourniquet and/or irrigation pump system.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Meniscus Rupture

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    20 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    NIR fluorescence
    Arm Type
    Experimental
    Arm Description
    The included patients will be subdivided in four equal subgroups in order to evaluate alteration of NIR fluorescence signal during arthroscopy in combination with a (temporary) tourniquet and irrigation pump system.
    Intervention Type
    Procedure
    Intervention Name(s)
    NIR fluorescence imaging of the vascular perfusion of the meniscus using ICG
    Intervention Description
    NIR fluorescence imaging of vascular perfusion using the Arthrex NIR fluorescence scope and Indocyanin Green
    Primary Outcome Measure Information:
    Title
    NIR fluorescence of the meniscus
    Description
    Detection of fluorescence in the meniscus (yes/no), determined intra-operatively during the arthroscopy procedure using NIR fluorescence imaging and ICG.
    Time Frame
    Fluorescence imaging will be performed from 0-10 minutes after injection of ICG
    Secondary Outcome Measure Information:
    Title
    T start
    Description
    Time between injection of ICG and initial detection of the fluorescence signal in the meniscus (T start).
    Time Frame
    Fluorescence imaging will be performed from 0-10 minutes after injection of ICG
    Title
    I max
    Description
    Maximum fluorescence intensity (Imax) in the meniscus. Fluorescence intensity will be measured in arbitrary units as a mean of three different region of interests.
    Time Frame
    Fluorescence imaging will be performed from 0-10 minutes after injection of ICG
    Title
    T max
    Description
    Time to maximum intensity of the fluorescence signal
    Time Frame
    0-10 minutes
    Title
    Baseline and End fluorescence intensity
    Description
    Baseline fluorescence intensity of the meniscus and the end fluorescence intensity in the meniscus
    Time Frame
    Fluorescence imaging will be performed from 0-10 minutes after injection of ICG
    Title
    The ration between the maximum fluorescence intensity in the meniscus and the background fluorecence intensity.
    Description
    The fluorescence intensity is measured in arbitrary units as a mean of three region of interests.
    Time Frame
    Fluorescence imaging will be performed from 0-10 minutes after injection of ICG

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: 18 years or older; Patients with on MRI confirmed Zone 1 meniscal tear Patients with a clinical indication for arthroscopic meniscal repair Before patient registration, written consent must be given according to ICH/GCP, national and local regulations. Exclusion Criteria: Prior operative treatment of the ruptured meniscus Any condition that in the opinion of the investigator could potentially jeopardize the health status of the patient. In specific, these conditions concern smoking, diabetes and being overweight. Pregnancy allergy to iodine, shellfish or ICG; Psychological, familial sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial;
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Pieter B.A.A. van Driel, MD, PhD
    Phone
    003188 6245000
    Email
    p.b.a.a.van.driel@isala.nl

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided
    Citations:
    PubMed Identifier
    23881033
    Citation
    Vahrmeijer AL, Hutteman M, van der Vorst JR, van de Velde CJ, Frangioni JV. Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol. 2013 Sep;10(9):507-18. doi: 10.1038/nrclinonc.2013.123. Epub 2013 Jul 23.
    Results Reference
    result
    PubMed Identifier
    34064948
    Citation
    Goncalves LN, van den Hoven P, van Schaik J, Leeuwenburgh L, Hendricks CHF, Verduijn PS, van der Bogt KEA, van Rijswijk CSP, Schepers A, Vahrmeijer AL, Hamming JF, van der Vorst JR. Perfusion Parameters in Near-Infrared Fluorescence Imaging with Indocyanine Green: A Systematic Review of the Literature. Life (Basel). 2021 May 11;11(5):433. doi: 10.3390/life11050433.
    Results Reference
    result
    PubMed Identifier
    34347140
    Citation
    van Schie P, van der Lelij TJN, Gerritsen M, Meijer RPJ, van Arkel ERA, Fiocco M, Swen JA, Vahrmeijer AL, Hazelbag HM, Keereweer S, van Driel PBAA. Intra-operative assessment of the vascularisation of a cross section of the meniscus using near-infrared fluorescence imaging. Knee Surg Sports Traumatol Arthrosc. 2022 May;30(5):1629-1638. doi: 10.1007/s00167-021-06690-w. Epub 2021 Aug 4.
    Results Reference
    result

    Learn more about this trial

    NIR Arthroscopic Fluorescence Angiography of Menisci

    We'll reach out to this number within 24 hrs